Antiprostasome antibody titres in benign and malignant prostate disease

Anticancer Research

Volumn 25, Issue 6 C, 2005, Pages 4399-4402

  Minelli, Alba ^a   Ronquist, Gunnar ^b   Carlsson, Lena ^b   Mearini, Ettore ^a   Nilsson, Ove ^c   Larsson, Anders ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Autoantibodies; Elisa; Prostasome; Prostate cancer; Prostate specific antigen

Indexed keywords

ANTIBODY; PROSTASOME ANTIBODY; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTASOME; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; SECRETORY GRANULE;

AGED; AGED, 80 AND OVER; ANTIBODIES, NEOPLASM; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROSTATITIS; SECRETORY VESICLES;

EID: 28444441898     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Isaacs JT: Molecular markers for prostate cancer metastasis. Am J Pathol 150: 1511-1521, 1997.
2. Bostwick DG, Grignon DJ, Hammond ME et al: Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124: 995-1000, 2000.
3. Koch MO, Foster RS, Bell B et al: Characterization and predictors of prostate specific antigen progression rates after radical retropubic prostatectomy. J Urol 164: 749-753, 2000.
4. Alers JC, Rochat J, Krijtenburg PJ et al: Identification of genetic markers for prostatic cancer progression. Lab Invest 80: 931-942, 2000.
5. Ronquist G and Brody I: The prostasome: its secretion and function in man. Biochim Biophys Acta 822: 203-218, 1985.
6. Ronquist G: Effect of modulators on prostasome membrane-bound ATPase in human seminal plasma. Eur J Clin Invest 17: 231-236, 1987.
7. Nilsson BO, Jin M, Einarsson B et al: Monoclonal antibodies against human prostasomes. Prostate 35: 178-184, 1998.
8. Sahlén G, Egevad L, Ahlander A et al: Ultrastructure of the secretion of prostasomes from benign and malignant epithelial cells in the prostate. Prostate 53: 192-199, 2002.
9. Nilsson BO, Egevad L, Jin M et al: Distribution of prostasomes in neoplastic epithelial prostate cells. Prostate 39: 36-40, 1999.
10. Sahlén G, Ahlander A, Frost A et al: Prostasomes are secreted from poorly differentiated cells of prostate cancer metastases. Prostate 61: 291-297, 2004.
11. Stegmayr B, Brody I and Ronquist G: A biochemical and ultrastructural study on the endogenous protein kinase activity of secretory granule membranes of prostatic origin in human seminal plasma. J Ultrastruct Res 78: 206-214, 1982.
12. Arvidson G, Ronquist G, Wikander G and Öjteg AC: Human prostasome membranes exhibit very high cholesterol/ phospholipid ratios yielding high molecular ordering. Biochim Biophys Acta 984: 167-173, 1989.
13. Arienti G, Carlini E, Polci A et al: Fatty acid pattern of human prostasome lipid. Arch Biochem Biophys 358(2): 391-395, 1998.
14. Utleg AG, Yi EC, Xie T et al: Proteomic analysis of human prostasomes. Prostate 56: 150-161, 2003.
15. Carlsson L, Ronquist G, Nilsson BO and Larsson A: Dominant prostasome immunogens for sperm-agglutinating autoantibodies of infertile men. J Androl 25: 699-705, 2004.
16. Hara N, Kasahara T, Kawasaki T et al: Frequency of PSA-mRNA-bearing cells in the peripheral blood of patients after prostate biopsy. Br J Cancer 85: 557-562, 2001.
17. Schleiermacher G and Delattre O: Detection of micrometastases and circulating tumour cells using molecular biology techniques in solid tumours. Bull Cancer 88: 561-570, 2001.
18. Siddall JK, Shetty SD and Cooper EH: Measurements of serum gammaseminoprotein and prostate specific antigen evaluated for monitoring carcinoma of the prostate. Clin Chem 32: 2040-2043, 1986.
19. Murphy GP, Tjoa BA, Simmons SJ et al: Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment. Prostate 39: 54-59, 1999.
20. Small EJ, Fratesi P, Reese DM et al: Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells. J Clin Oncol 18: 3894-3903, 2000.
21. Nouri-Shirazi M, Banchereau J, Bell D et al: Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J Immunol 165: 3797-3803, 2000.
22. Harris DT, Matyas GR, Gomella LG et al: Immunologic approaches to the treatment of prostate cancer. Semin Oncol 26: 439-447, 1999.
23. Meidenbauer N, Harris DT, Spitler LE and Whiteside TL: Recovery of zeta-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancer. Br J Cancer 86: 168-178, 2002.
24. Nilsson BO, Carlsson L, Larsson A and Ronquist G: Autoantibodies to prostasomes as new markers for prostate cancer. Upsala J Med Sci 106: 43-50, 2001.
25. Larsson A, Ronquist G, Wülfing C et al: Antiprostasome antibodies: possible serum markers for prostate cancer metastasizing liability. Urol Oncol, in press, 2005.
26. Whitmore WF: Localised prostate cancer management and detection issues. Lancet 343: 1263-1267, 1994.
27. Sakr WA, Haas GP, Cassin BF et al: The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 150: 379-385, 1993.
28. Pavlenko M, Roos AK, Lundqvist A et al: A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer. Br J Cancer 91: 688-694, 2004.
29. Carlsson L, Larsson A, Ronquist G and Nilsson BO: Prostasome antigens as targets for sperm agglutinating antibodies demonstrated by 1-D gel electrophoresis and immunoblottings. Int J Androl 27: 360-367, 2004.
30. Tenniswood M, Wang Z, Lakins J et al: Clusterin in the male reproductive tract. J Androl 79: 508-516, 1998.
31. Hochgrebe TT, Humphreys D, Wilson MR and Easterbrook-Smith SB: A reexamination of the role of clusterin as a complement regulator. Exp Cell Res 249: 13-21, 1999.
32. Bailey R and Griswold MD: Clusterin in the male reproductive system localization and possible function. Mol Cell Endocrinol 15: 17-23, 1999.